DISCLAIMER
The information on this website has not been independently verified as to correctness or completeness and this document does therefore not purport to be correct or complete. This website does not constitute an audit, a due diligence or any similar review and should not be construed as such nor does it serve as a respective substitute. This website should therefore not form the basis of any decision be relied on for any purpose and should not in any way serve as a substitute for other enquiries and procedures that would (or should) otherwise be undertaken.
To the extent permitted by law no representation or warranty, expressed or implied, is or will be made and no responsibility or liability is or will be accepted by the Company or by any of their respective directors, officers, servants, advisers, agents or affiliates as to or in relation to the accuracy, sufficiency or completeness of this document or the information forming the basis of the document or for any errors, omissions or misstatements relating thereto. In particular, without limitation, no representation or warranty, expressed or implied, is or will be made as to the achievement or reasonableness of, and no reliance should be placed on, any projection, targets, estimates, forecasts and nothing in this document should be relied on as a promise or representation as to the future.
The Fund Documents and this website of are for information purposes only. Nothing contained therein constitutes or shall be deemed to constitute a financial, legal, tax or other advice of any kind and no information on the website shall constitute or deem to constitute a solicitation or an offer to purchase, or invest in, any financial products which are referred to on this website. This website is specifically not aimed at parties who are residents of any country where the funds referred to herein are not registered or approved for marketing and/or sale or dissemination of information on the funds or services is not permitted. 4 BIO cannot make any representation or warranty of any nature, expressly or implicitly, about the fund documents. You should not rely solely on the information contained on the Website.
DISCLOSURE STATEMENT
4BIO Partners, LLP (the “firm”) is an SEC registered investment adviser with its principal place of business in the United Kingdom. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability. The firm and its representatives are in compliance with the current notice filing and registration requirements imposed upon registered investment advisers by those states in which the firm maintains clients. The firm may only transact business in those states in which it is notice filed, or qualifies for an exemption or exclusion from notice filing requirements. This web site is limited to the dissemination of general information pertaining to its investment advisory/management services. Investing in the stock market involves gains and losses and may not be suitable for all investors. Any subsequent, direct communication by the firm with a prospective client shall be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides. For information pertaining to the registration status of the firm, please contact the firm or refer to the Investment Adviser Public Disclosure web site (www.adviserinfo.sec.gov).
This site may provide links to other web sites. Third parties, over whom the firm exercises no control, maintain these web sites. The firm expressly disclaims any responsibility for the content, accuracy of information, and availability of and/or quality of products, services or software provided by or advertised on any third-party web sites. If you leave this site through a hyperlink, or any other means, you do so at your own risk. The firm is not responsible or liable for any content or other materials on or available through such sites or any losses related thereto.
Any commentary that cannot be removed by the firm placed by a third party for circumstances relating to the third-party site or on the firm’s site should not be interpreted as an endorsement or testimonial by the firm.
For additional information about the firm, including fees and services, send for our disclosure statement as set forth on Form ADV. Please read the disclosure statement carefully before you invest or send money.
SFDR DISCLOSURE
Mandatory disclosures under Regulation of the European Parliament and of the Council on sustainable-related disclosures in the financial services sector (EU) 2019/2088 (“SFDR”).
4BIO Partners LLP (“4BIO Capital”) considers sustainability risks as part of its investment decision-making process. Sustainability risks are environmental, social or governance events or conditions, the occurrence of which could have an actual or potential material adverse effect on the value of the investment. 4BIO Capital remains free in its decision to refrain from investing or to invest despite sustainability risks in which case 4BIO Capital can also apply measures to reduce or mitigate any sustainability risks. At all times, 4BIO Capital will apply the principle of proportionality taking due account of the strategic relevance of an investment as well as its transactional context.
4BIO Capital pursues a venture capital strategy and invests in companies within the advanced therapies sector. Given that there are rarely adverse impacts on sustainability factors within advanced therapies 4BIO Capital does not formally consider adverse impacts of investment decisions on sustainability, however, should there occur adverse impacts during the investment process, 4BIO Capital will evaluate those adverse impacts and in case of a negative outcome will refrain from an investment.
4BIO Capital has not identified any adverse sustainability impacts related to its investments to date.
Given that the Sustainable Finance Disclosure Regulation (EU 2019/2088) (“SFDR“) and the accompanying Regulatory Technical Standards (“RTS“) are new legislative acts, there is very little or no practical experience or practice with regard to applying their respective provisions. Therefore, substantial legal uncertainties would remain when applying those provisions to the strategies pursued by 4BIO Capital. If and to the extent that these uncertainties will be resolved and a practicable market and administrative practice will evolve in this regard, 4BIO Capital will reevaluate following them in due course.
At 4BIO Capital we stand by the principles of responsible investment in our internal and external processes and policies to ensure alignment with our fundamental commitment to pursuing long-term financial returns for our clients. We are signatories of UN Principles for Responsible Investment.
Kanto Local Finance Bureau regulatory compliance: